Health-Related Quality of Life (HR-QOL) and Regulatory Issues: An Assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) Recommendations on the Use of HR-QOL Measures in Drug Approval

Author： Apolone G.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.19, Iss.2, 2001-01, pp. : 187-195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Limited attention is paid to health-related quality-of-life (QOL) issues

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 305, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

The use of once-weekly epoetin-α has no effect on health-related quality of life (HRQOL) in children with cancer,

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 511, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

The use of once-weekly epoetin-α has no effect on health-related quality of life (HRQOL) in children with cancer

By  

Inpharma, Vol. 1, Iss. 1554, 2006-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

The Role of Health-Related Quality of Life Data in the Drug Approval Processes in the US and Europe: A Review of Guidance Documents and Authorizations of Medicinal Products from 2006 to 2010

By Marquis Patrick  

Pharmaceutical Medicine, Vol. 25, Iss. 3, 2011-06 ,pp. : 147-160

Adis International

Access to resources Recommend Favorite

The Cystic Fibrosis Questionnaire (CFQ) is a "reliable and valid" measure of health-related (HR) QOL for adolescents and adults with cystic fibrosis

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 494, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite